Gilead Sciences

Overview

Gilead Sciences is a biopharmaceutical company founded in 1987 and headquartered in the United States, with a workforce exceeding 10,000 employees. The company operates primarily in the research and development sector of the biotech and pharmaceuticals industry. Gilead is engaged in various initiatives, including the formulation of Carbon Reduction Plans aimed at achieving net-zero emissions by 2050. These plans require suppliers to provide detailed accounts of their carbon footprints and commitments to emission reductions, demonstrating Gilead's focus on sustainability and environmental responsibility. Additionally, Gilead supports medical education and research through programs such as fellowships and grants, which are designed to enhance knowledge sharing and collaboration within the medical community. The company also emphasizes patient-centric approaches in its service offerings, as highlighted in its documentation on CAR-T therapies, which reflects its commitment to innovative treatment solutions. Overall, Gilead Sciences is dedicated to advancing healthcare while addressing environmental challenges and fostering educational initiatives within the medical field.

Industry